The end of hydroxychloroquine as a treatment for COVID-19

A safer MRI contrast agent for high-resolution 3D microvascular imaging
10 March 2021
Researchers develop guidelines for reporting polygenic risk scores
10 March 2021

The end of hydroxychloroquine as a treatment for COVID-19

A year ago, infectious disease doctor Christine Johnston was leading a study on the use of hydroxychloroquine for the treatment of people with COVID-19.

Comments are closed.